Literature DB >> 23221844

Lyme disease: a multisystem infection that affects the nervous system.

John J Halperin1.   

Abstract

PURPOSE OF REVIEW: This article will enable the reader to diagnose and treat nervous system Lyme disease appropriately. RECENT
FINDINGS: Appropriately applied serologic testing has high positive and negative predictive values in nervous system Lyme disease. Oral antibiotics can be curative in most cases.
SUMMARY: Infection with the tick-transmitted spirochete Borrelia burgdorferi causes Lyme disease, a disorder that involves the nervous system in about 15% of patients. Common manifestations include lymphocytic meningitis, cranial neuritis (particularly cranial nerve VII), painful radiculitis, other forms of mononeuropathy multiplex, and rarely CNS parenchymal involvement. Diagnosis is supported primarily by demonstration of anti-B. burgdorferi antibodies in serum. CSF examination can be informative in problematic cases with parenchymal CNS infection or to identify meningitis. However, oral antibiotics are probably effective in patients with meningitis and other forms of involvement, with the likely exception of parenchymal CNS infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23221844     DOI: 10.1212/01.CON.0000423850.24900.3a

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  10 in total

1.  [Papilledema and thought disorder].

Authors:  S Waibel; L E Pillunat; E Matthé
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

2.  Imaging in neurologic infections I: bacterial and parasitic diseases.

Authors:  Pooja Raibagkar; Martha R Neagu; Jennifer L Lyons; Joshua P Klein
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

Review 3.  [Neuroborreliosis - Diagnostics, treatment and course].

Authors:  R Dersch; S Rauer
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

4.  Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.

Authors:  Elzbieta Jacek; Kevin S Tang; Lars Komorowski; Mary Ajamian; Christian Probst; Brian Stevenson; Gary P Wormser; Adriana R Marques; Armin Alaedini
Journal:  J Immunol       Date:  2015-12-30       Impact factor: 5.422

Review 5.  Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review.

Authors:  R Dersch; H Sommer; S Rauer; J J Meerpohl
Journal:  J Neurol       Date:  2015-10-12       Impact factor: 4.849

6.  Diplopia: A Rare Manifestation of Neuroborreliosis.

Authors:  Ayushi Dixit; Yesika Garcia; Lauren Tesoriero; Charles Berman; Vincent Rizzo
Journal:  Case Rep Neurol Med       Date:  2018-07-09

7.  Lyme disease: case report of persistent Lyme disease from Pulaski County, Virginia.

Authors:  James R Palmieri; Scott King; Matthew Case; Arben Santo
Journal:  Int Med Case Rep J       Date:  2013-12-05

8.  Efficacy and safety of pharmacological treatments for neuroborreliosis--protocol for a systematic review.

Authors:  Rick Dersch; Michael H Freitag; Stefanie Schmidt; Harriet Sommer; Gerta Rücker; Sebastian Rauer; Joerg J Meerpohl
Journal:  Syst Rev       Date:  2014-10-21

9.  Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.

Authors:  Venkata Raveendra Pothineni; Hari-Hara S K Potula; Aditya Ambati; Venkata Vamsee Aditya Mallajosyula; Brindha Sridharan; Mohammed Inayathullah; Mohamed Sohail Ahmed; Jayakumar Rajadas
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

10.  Chronic Meningitis: Simplifying a Diagnostic Challenge.

Authors:  Kelly Baldwin; Chris Whiting
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 6.030

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.